GlassScriptPhysician profile
Dzuy Luu
NPI 1912284795
$2,796.97
in general payments reported to CMS, 2019-2025
12 companies · $49.00 in 2025
The $49.00 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,297 · 2022: $964 · 2023: $284 · 2024: $203 · 2025: $49.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $1,713.49 | 2021-2022 | |
| Smith+Nephew, INC. | $260.20 | 2021-2025 | Allevyn Heel 10.5cm X 13.5cm Ctn 5, Collagenase Santyl |
| Next Science LLC | $233.17 | 2023-2024 | Surgx, Blastx, Xperience |
| Kci USA, INC. | $145.86 | 2022-2023 | V.A.C. Veraflo |
| Glaxosmithkline, LLC. | $124.99 | 2023 | Arexvy |
| Abbvie INC. | $124.97 | 2021 | |
| Organogenesis INC. | $41.77 | 2021 | |
| Janssen Pharmaceuticals, INC | $40.93 | 2021 | |
| Paratek Pharmaceuticals, INC. | $37.80 | 2021 | |
| Solventum Corporation | $30.00 | 2025 | Activ.A.C. |
| Sanofi-Aventis U.S. LLC | $29.95 | 2022 | |
| Mannkind Corporation | $13.84 | 2023 | Afrezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dzuy Luu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.